Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

about

Yale School of Public Health Symposium on tissue imaging mass spectrometry: illuminating phenotypic heterogeneity and drug disposition at the molecular level.

P2860

Q50348522-2417FCD4-6C69-4FA7-A425-7794E4D4622D

P2860

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

Item

http://www.wikidata.org/entity/Q41124799

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mass Spectrometry Imaging prov ...... rs along the crypt-villus axis

@en

type

Item

label

Mass Spectrometry Imaging prov ...... rs along the crypt-villus axis

@en

prefLabel

Mass Spectrometry Imaging prov ...... rs along the crypt-villus axis

@en

P1476

Mass Spectrometry Imaging prov ...... rs along the crypt-villus axis

@en

P2093

Alexandra Peric

http://www.w3.org/2001/XMLSchema#string

Anna Nilsson

http://www.w3.org/2001/XMLSchema#string

Marie Strimfors

http://www.w3.org/2001/XMLSchema#string

Richard J A Goodwin

http://www.w3.org/2001/XMLSchema#string

P2860

In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studies

Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry.

Quantitative imaging mass spectrometry of renal sulfatides: validation by classical mass spectrometric methods.

Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.

Direct imaging of single cells and tissue at sub-cellular spatial resolution using transmission geometry MALDI MS.

msIQuant--Quantitation Software for Mass Spectrometry Imaging Enabling Fast Access, Visualization, and Analysis of Large Data Sets.

Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

Caco-2 monolayers in experimental and theoretical predictions of drug transport.

Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method.

Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor.

P2888

s41598-017-06583-4

P304

6352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-06583-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Hilgendorf

Per E Andrén

Martin A Hayes

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28743866

http://www.w3.org/2001/XMLSchema#string

P932

5526999

http://www.w3.org/2001/XMLSchema#string

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

about

P2860

P2860

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932